about
Potential of adipose-derived stem cells in muscular regenerative therapiesA highly conserved molecular switch binds MSY-3 to regulate myogenin repression in postnatal muscleFunctional interdependence at the chromatin level between the MKK6/p38 and IGF1/PI3K/AKT pathways during muscle differentiation.Epigenetic reprogramming of human embryonic stem cells into skeletal muscle cells and generation of contractile myospheres.TNF/p38α/polycomb signaling to Pax7 locus in satellite cells links inflammation to the epigenetic control of muscle regeneration.Signaling to the chromatin during skeletal myogenesis: novel targets for pharmacological modulation of gene expression.Epigenetic control of reprogramming and cellular differentiation.A cellular model reflecting the phenotypic heterogeneity of mutant HRAS driven squamous cell carcinoma.Dynamics and dispensability of variant-specific histone H1 Lys-26/Ser-27 and Thr-165 post-translational modifications.Emerging roles of macrosatellite repeats in genome organization and disease development.Characterization of Trex1 induction by IFN-γ in murine macrophages.Downregulation of the Deiminase PADI2 Is an Early Event in Colorectal Carcinogenesis and Indicates Poor Prognosis.p38 pathway targets SWI-SNF chromatin-remodeling complex to muscle-specific loci.Deacetylase recruitment by the C/H3 domain of the acetyltransferase p300.The BAF60c-MyoD complex poises chromatin for rapid transcription.Second German-Catalan workshop on epigenetics & cancer.Evaluation of commercial dysferlin antibodies on canine, mouse and human skeletal muscle.Barcelona conference on epigenetics and cancer 2016 - beyond cancer genomes.Selective control of Pax7 expression by TNF-activated p38α/polycomb repressive complex 2 (PRC2) signaling during muscle satellite cell differentiation.A novel long non-coding RNA from NBL2 pericentromeric macrosatellite forms a perinucleolar aggregate structure in colon cancer.Spotlight on epigenetic reprogramming in cardiac regenerationChromatin status is key for regeneration"Verteporfin exhibits anti-proliferative activity in embryonal and alveolar rhabdomyosarcoma cell lines"
P50
Q26798810-7EAFB670-FDEF-4F8C-9D3D-721BD2C26A7AQ28505520-0B44EF7A-16DF-48F0-933A-6FA914FB3919Q30439474-D0338B15-85F2-46D8-A892-F4A5A8F4577CQ30538794-89BB324F-DD6C-4665-96F0-39A27E56B976Q34181742-62F2B720-0552-4795-B54F-46430CBE5E8CQ36243868-9A37AEEB-0AB9-484D-A3AE-E109BD2725C1Q36277560-D18ADB86-B5BF-4FC5-98F0-6160F7824AEDQ38778567-A67E39B7-C22A-4B1A-B8E0-8DB7E9553DC1Q38990534-A36F8683-8423-470C-A60E-A7B8DF14C41CQ39252070-30C0F8DD-B0B9-431E-8466-EE721C07CCFCQ39607217-4EAAF356-7B8D-4F81-91BA-798C7046EEDBQ39697047-6D54DCFF-88CD-4422-BA34-C2652CEA41F1Q40543190-18C44860-21EE-4453-822A-46E8E1BCF231Q40589176-30401284-4CF9-4BC4-886C-023B53181A08Q42266611-6BB1F132-8991-4256-AD20-4E09C02D79FDQ42601540-D69CB32C-5253-48EE-9F4E-2B22A7361460Q42917509-F5A97C54-A3D5-4F15-8B74-91FA0CB493ACQ47577915-3A7449F1-A086-46FC-ADFF-C0A4EA56FC93Q54621034-8716C308-58D4-4845-BF6A-90CE0D559BC1Q55346622-66CE28D5-AEEC-4CA0-AC15-60F6865F9A00Q90015889-1E7494BB-848E-4248-86C6-4F7E7CC4D7B4Q92772062-D4910839-FC3B-42D2-9B64-7C90ECE00EEFQ93169412-DD590DF9-E2AB-4178-8DA6-4AAC518BF3D0
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Sonia Forcales
@ast
Sonia Forcales
@en
Sonia Forcales
@es
Sonia Forcales
@nl
Sonia Forcales
@sl
type
label
Sonia Forcales
@ast
Sonia Forcales
@en
Sonia Forcales
@es
Sonia Forcales
@nl
Sonia Forcales
@sl
prefLabel
Sonia Forcales
@ast
Sonia Forcales
@en
Sonia Forcales
@es
Sonia Forcales
@nl
Sonia Forcales
@sl
P108
P1053
B-2157-2013
P106
P108
P1153
6507950682
P21
P31
P3829
P496
0000-0002-7111-4959